AR and prostate cancer: Another study showed that two glutamine transporters—SCL1A4 and SCL1A5—whose expression is stimulated by AR, are overexpressed in prostate cancer cells and stimulate glutamine uptake by these tumor cells and are required for maximal AR-driven proliferation [466].